development on The Soothsayer / page 2

OpenAI’s AI Training Data Debacle: A Copyright Lawsuit’s Unforeseen Twist

In a surprising turn of events, OpenAI has accidentally deleted data potentially relevant to a copyright lawsuit filed by The New York Times and Daily News. The lawsuit alleges that OpenAI scraped their works to train its AI models without permission. OpenAI engineers erased the data, but were able to recover most of it, albeit…

Nuclear Shapes Unveiled: Breakthrough in Particle Physics

Scientists in the STAR Collaboration have made a groundbreaking discovery by developing a new method to investigate the shapes of atomic nuclei through high-energy collisions. This innovative approach offers unprecedented insight into nuclear structure and promises to deepen our understanding of strong nuclear forces and their role in the composition of neutron stars and the…

Bispecific Antibodies: The Future of Cancer Treatment?

The biotech industry is witnessing a surge in the development of bispecific antibodies, a type of targeted therapy that can deliver two-in-one treatments to patients with cancer and other diseases. Several companies, including Adaptin Bio, Akeso, AP Biosciences, Candid Therapeutics, Summit Therapeutics, and Zenas BioPharma, are working on various bispecific antibody candidates, some of which…

San Francisco’s New Mayor Taps OpenAI CEO Sam Altman for Transition Team

San Francisco’s mayor-elect, Daniel Lurie, has appointed OpenAI CEO Sam Altman to help lead his transition team. Altman will provide guidance on how the city can innovate and develop relationships with key partners. This move is seen as an effort to attract young professionals and convince current tech entrepreneurs to stay in the city. In…

Breakthrough in Lung Cancer Detection: Nanoflake-Based Breath Sensor Shows Promise

Researchers from China and Spain have developed a nanoflake-based breath sensor that can detect lung cancer with unprecedented accuracy. The sensor, made from platinum-loaded nanoflakes, can detect isoprene levels in exhaled breath, a biomarker for lung cancer. The device has shown promising results in clinical trials, distinguishing between healthy individuals and lung cancer patients with…

Three Cryptocurrencies to Watch in November 2024

Qubetics, Binance, and Avalanche are emerging as top contenders in the cryptocurrency market, driven by innovative approaches and promising future growth. Qubetics is simplifying blockchain development with its QubeQode IDE, while Binance is expanding its reach through partnerships with Google Cloud. Avalanche is proving its scalability and focus on innovative projects like the Libeara Fund….

Breakthrough in Cancer Treatment: Hybrid Irradiation Could Revolutionize Radiotherapy

Researchers in Switzerland have made a significant breakthrough in cancer treatment by developing a hybrid approach that combines ultrahigh-dose-rate (UHDR) electron beams with conventional dose-rate (CDR) photon beams. This innovative technique, known as FLASH radiotherapy, has the potential to spare healthy tissues while effectively targeting malignant tumour cells. The study, published in Radiotherapy and Oncology,…

Exosome Therapy Companies Lead the Way in Personalized Medicine

The biotech industry is witnessing a surge in the development of exosome therapy companies, which are harnessing the potential of these tiny vesicles to treat a range of diseases, including cancer, neurological disorders, and inflammatory diseases. With several companies advancing their candidates through clinical trials, the global exosome therapeutics market is expected to grow significantly…

AI Models at Risk of Collapse: A Threat to Synthetic Content

Researchers warn that generative AI models, trained on their own synthetic content, may collapse and produce nonsensical responses. This could exacerbate bias and lead to a loss of nuance in AI-generated text. Experts suggest that using a combination of human-generated and AI-generated data for training can help prevent this collapse. Forecast for 6 months: In…

Breakthroughs in Cystic Fibrosis Treatment: A New Era of Hope

Cystic fibrosis is a debilitating genetic disorder that affects nearly 40,000 children and adults in the US. Recent advancements in biotechnology have led to the development of innovative treatments, including gene therapies and CFTR modulators. Companies like Enterprise Therapeutics, Krystal Biotech, Recode Therapeutics, Sionna Therapeutics, and Vertex Pharmaceuticals are at the forefront of this research,…

Wordpress Social Share Plugin powered by Ultimatelysocial
RSS
Follow by Email
LinkedIn
Share
WhatsApp
URL has been copied successfully!